MESROPYAN et al.
970
5-Morpholinomethyl-3-(2-morpholinoethyl)-
0.02 mol, was then added, and the mixture was heated
for 4 h more, diluted with 30 ml of water, and acidified
with 1.75 ml of 11.54 M hydrochloric acid. The precip-
itate was filtered off and recrystallized from water.
tetrahydrofuran-2-one (VII). Yield 3.5 g (59%),
bp 230°C (4 mm), mp 78–80°C (from hexane), Rf 0.25
(EtOH–MeOH–C2H4Cl2–H2O, 1.1:1.3:0.5:1.5). IR
1
spectrum: ν 1759 cm–1 (C=O). H NMR spectrum, δ,
Compound X. Yield 2.9 g (60%), mp 250–255°C
(decomp.), Rf 0.47 (EtOH–MeOH–MeCN–C2H4Cl2–
H2O, 1.0 :1.0 :1.0 :0.4 :1.0). IR spectrum, ν, cm–1:
3493, 3419, 3303, 3107 (NH, =C–OH), 1723, 1706,
ppm: 1.44–1.66 m (2H, 4-H), 1.82–2.20 m (2H,
3-CH2), 2.32–2.57 m (6H, CH2N), 2.68 m (1H, 3-H),
3.51–3.62 m (8H, CH2O), 4.50 m (0.8H, 5-H), 4.59 m
(0.2H, 5-H). Found, %: C 60.62; H 9.05; N 9.68.
C15H26N2O4. Calculated, %: C 60.38; H 8.78; N 9.39.
1
1700, 1696, 1670 (C=O), 1607 (=C–OH). H NMR
spectrum, δ, ppm: in DMSO-d6: 2.59 t (2H, 5-CH2),
3.07 t (2H, 5-CH2CH2), 2.80–3.60 br.s (4H, CH2N),
3.75 br.s (5H, CH2O, 5-H), 10.86 s (2H, NH); in
DMSO-d6–CF3COOD: 2.64 t (2H, 5-CH2), 3.03 br.m
(2H, 5-CH2CH2), 3.11 t (2H, CH2N), 3.55 br.m (2H,
CH2N), 3.71 br.m (2H, CH2O), 3.92 br.m (2H, CH2O).
Found, %: C 50.08; H 6.53; N 17.69. C10H15N3O4. Cal-
culated, %: C 49.79; H 6.27; N 17.42.
5-[Ethyl(phenyl)aminomethyl]-3-(2-morpholino-
ethyl)tetrahydrofuran-2-one (VIII). Yield 3.7 g
(56%), bp 250°C (4 mm), mp 86°C (from hexane),
Rf 0.47 (C2H4Cl2–C6H14–MeOH, 2.0:1.1:0.5). IR
spectrum, ν, cm–1: 1769 (C=O), 3032 (C–Harom), 1605
1
(C=Carom). H NMR spectrum, δ, ppm: 1.15 t (3H,
CH3), 1.44–1.66 m (2H, 4-H), 1.82–2.21 m (2H,
3-CH2), 2.35–2.52 m (6H, CH2N), 2.72 m (1H, 3-H),
3.40–3.64 m (8H, CH2O, 5-CH2), 4.59 m (0.85H, 5-H),
4.69 m (0.15H, 5-H); 6.59 m, 6.65 m, and 7.16 m
(5H, Harom). Found, %: C 68.37; H 8.22; N 8.17.
C19H28N2O3. Calculated, %: C 68.65; H 8.49; N 8.43.
Compound XI. Yield 3.2 g (62%), mp 280–287°C
(decomp.), Rf 0.5 (EtOH–MeOH–MeCN–C2H4Cl2–
H2O, 1.0 :1.0 :1.0 :0.4 :0.4). IR spectrum, ν, cm–1:
3449, 3348, 3172 (NH, =C–XH), 1670, 1650, 1615
(C=O), 1576 (=C–XH). 1H NMR spectrum, δ, ppm: in
DMSO-d6: 2.59 t (2H, 5-CH2), 3.07 t (2H, 5-CH2CH2),
2.80–3.60 br.s (4H, CH2N), 3.79 br.s (5H, CH2O, 5-H),
10.92 s (2H, NH); in DMSO-d6–CF3COOD: 2.64 t
(2H, 5-CH2), 3.03 br.m (2H, 5-CH2CH2), 3.15 t (2H,
CH2N), 3.55 br.m (2H, CH2N), 3.71 br.m (2H, CH2O),
3.92 br.m (2H, CH2O). Found, %: C 46.90; H 6.02;
N 16.59. C10H15N3O3S. Calculated, %: C 46.68;
H 5.88; N 16.33.
Ethyl 3-(2-morpholinoethyl)-2-oxo-5-(piperi-
dinomethyl)tetrahydrofuran-3-carboxylate (IX).
Metallic sodium, 0.46 g (0.02 mol), was added in small
pieces to a solution of 5.46 g (0.02 mol) of compound
I in 9 ml of ethanol. When the mixture warmed up to
45°C, 1.85 g (1.56 ml, 0.02 mol) of epoxide V was
added dropwise, and the mixture was heated for 3 h at
45–50°C. Piperidine, 1.7 g (1.95 ml, 0.02 mol), was
then added, the mixture was heated for 2 h at 45–50°C,
and 30 ml of ethanol was added. The mixture was
filtered, the filtrate was dried over MgSO4 and evap-
orated to dryness, and the residue was extracted with
hot hexane to isolate butanolide IX. Yield 3.4 g (46%),
nD24 = 1.4932, Rf 0.53 (C2H4Cl2–C6H14–EtOH, 1.2:0.8:
0.2). IR spectrum, ν, cm–1: 1778 (C=O, lactone), 1730
REFERENCES
1. Baylon, C., Prestat, G., Heck, M.-P., and Mioskowski, C.,
Tetrahedron Lett., 2000, vol. 41, p. 3833.
2. Marion, F., Le Fol, R., Courillon, C., and Malacria, M.,
Synlett, 2001, p. 138.
3. Surivet, J.-P., Gore, J., and Vatele, J.-M., Tetrahedron
Lett., 1996, vol. 37, p. 371.
4. Ono, M., Saotome, C., and Akita, H., Heterocycles, 1999,
vol. 51, p. 1503.
5. Mesropyan, E.G., Ambartsumyan, G.B., Galstyan, A.S.,
and Avetisyan, A.A., Khim. Zh. Arm., 2003, vol. 56, p. 67.
6. Mashkovskii, M.D., Lekarstvennye sredstva (Drugs),
1
(C=O, ester). H NMR spectrum, δ, ppm: 1.10 t (3H,
CH3), 1.20–1.70 m (8H, CH2), 1.82–2.20 m (2H,
3-CH2), 2.32–2.57 m (12H, CH2N), 3.54 m (6H,
CH2O), 4.50 m (0.85H, 5-H), 4.59 m (0.15H, 5-H).
Found, %: C 62.16; H 9.03; N 7.94. C19H32N2O5. Cal-
culated, %: C 61.93; H 8.75; N 7.60.
5-(2-Morpholinoethyl)hexahydropyrimidine-
2,4,6-trione (X) and 5-(2-morpholinoethyl)-2-
thioxohexahydropyrimidine-4,6-dione (XI) (general
procedure). Compound I, 5.46 g (0.02 mol), was added
dropwise to a solution of sodium methoxide prepared
from 8 ml of anhydrous methanol and 0.46 g
(0.02 mol) of metallic sodium, and the mixture was
heated for 10 min under reflux. Urea or thiourea,
Moscow: Novaya Volna, 2002, vols. 1, 2.
7. Belikov, V.G., Farmatsevticheskaya khimiya (Pharma-
ceutical Chemistry), Moscow: Vysshaya Shkola, 1985.
8. Mesropyan, E.G., Galstyan, A.S., and Avetisyan, A.A.,
Russ. J. Org. Chem., 2006, vol. 42, 1845.
9. Khramkina, M.N., Praktikum po organicheskomu sintezu
(Practicum on Organic Synthesis), Leningrad: Khimiya,
1977, p. 36.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 46 No. 7 2010